- Home
- HAIN vs PLRX Comparison
HAIN vs PLRX Comparison
Compare HAIN & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAIN | PLRX |
|---|---|---|
| Founded | 1993 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.6M | 93.3M |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HAIN | PLRX |
|---|---|---|
| Price | $1.05 | $1.52 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 11 |
| Target Price | $2.91 | ★ $3.79 |
| AVG Volume (30 Days) | ★ 1.8M | 762.4K |
| Earning Date | 11-07-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,533,067,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.91 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $1.10 |
| 52 Week High | $8.69 | $15.80 |
Technical Indicators
Market Signals| Indicator | HAIN | PLRX |
|---|---|---|
| Relative Strength Index (RSI) | 35.69 | 42.21 |
| Support Level | $1.10 | $1.48 |
| Resistance Level | $1.13 | $1.63 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 0.00 | 10.45 |
Price Performance
Historical ComparisonAbout HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.